Mylan Sued By EpiPen Buyers Over Pricing, Marketing Tactics
Mylan was hit with a proposed class action in California federal court on Monday alleging that EpiPen price hikes in excess of 500 percent over the last decade have ripped off...To view the full article, register now.
Already a subscriber? Click here to view full article